Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (7)
Type
(
1 selected
)
Type
Guidance (1961)
NICE advice (319)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (226)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (27)
Highly specialised technologies guidance (30)
Interventional procedures guidance (611)
Medical technologies guidance (66)
Medicines practice guidelines (5)
NICE guidelines (337)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (70)
Technology appraisal guidance (840)
Apply filters
Showing 611 to 620 of 1961
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Entecavir for the treatment of chronic hepatitis B
TA153
27 August 2008
27 August 2008
Entrectinib for treating NTRK fusion-positive solid tumours
TA644
12 August 2020
12 August 2020
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer
TA643
12 August 2020
12 August 2020
Enzalutamide for hormone-relapsed non-metastatic prostate cancer
TA580
15 May 2019
15 May 2019
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen
TA316
23 July 2014
23 July 2014
Enzalutamide for treating hormone-sensitive metastatic prostate cancer
TA712
7 July 2021
7 July 2021
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
TA377
27 January 2016
27 January 2016
Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal)
TA994
8 August 2024
8 August 2024
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
TA954
6 March 2024
6 March 2024
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer
IPG784
2 April 2024
2 April 2024
Previous page
1
…
60
61
Current page
62
63
64
…
197
Page
62
of
197
Next page
Results per page
10
25
50
All
Back to top